{"schema_version":"secwatch.filing_event.v1","accession":"0001156039-24-000093","form_type":"8-K","ticker":"ELV","cik":"0001156039","company_name":"Elevance Health, Inc.","filed_at":"2024-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.470254+00:00","generated_at":"2026-06-01T04:47:14.539571+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Elevance Health reaffirms FY2024 net income >$34.05, adjusted >$37.20 per share","bullets":["Net income guidance for FY2024 greater than $34.05 per diluted share including approximately $3.15 per share of net unfavorable items.","Adjusted net income guidance greater than $37.20 per diluted share, excluding the unfavorable items.","Guidance does not include any adjustment items beyond those reported in Q1 2024 earnings release.","Company officers reaffirming guidance during investor meetings over the next several weeks."],"urls":{"canonical":"https://secwatch.observer/filing/0001156039-24-000093","json":"https://secwatch.observer/filing/0001156039-24-000093.json","markdown":"https://secwatch.observer/filing/0001156039-24-000093.md","text":"https://secwatch.observer/filing/0001156039-24-000093.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000093/0001156039-24-000093-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000093/item701guidancejune2024.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:47:14.539571+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}